Artwork

Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Adapting Biopharma to AI: A 2024 Update with Greg Meyers

25:55
 
Share
 

Manage episode 436487780 series 2790733
Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, or BMS, joins Jorge Conde, general partner at a16z.

This is a follow-up to their 2023 episode, where they discussed how biopharma can adapt to AI. Now, they revisit the conversation to see what’s changed and what hasn’t.

Together, they chat through tech as a competitive differentiator for large companies, generative AI for drug development, and what Greg and BMS look for in potential partners. They also highlight the importance of being agile and adaptable while navigating the changing landscape of biotech, providing valuable insights for founders.

  continue reading

167 episodes

Artwork
iconShare
 
Manage episode 436487780 series 2790733
Content provided by a16z, Andreessen Horowitz, and A16z Bio + Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by a16z, Andreessen Horowitz, and A16z Bio + Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, or BMS, joins Jorge Conde, general partner at a16z.

This is a follow-up to their 2023 episode, where they discussed how biopharma can adapt to AI. Now, they revisit the conversation to see what’s changed and what hasn’t.

Together, they chat through tech as a competitive differentiator for large companies, generative AI for drug development, and what Greg and BMS look for in potential partners. They also highlight the importance of being agile and adaptable while navigating the changing landscape of biotech, providing valuable insights for founders.

  continue reading

167 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide